Hyaluronic Acid Market Size, Trends and Insights By Grade (Food, Cosmetic, Pharmaceutical), By Application (Pharmaceutical API, Aesthetics, Osteoarthritis, Cosmetics, Ophthalmology, Dietary Supplements), By End-users (Pharmaceuticals Industry, Cosmetic Surgery Centers, Dermatology Clinics, Food Industry, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
CAGR: 8%
| Study Period: | 2025-2034 |
| Fastest Growing Market: | North America |
| Largest Market: | Asia Pacific |
Major Players
- Allergan
- Genzyme Corporation
- Sanofi
- Anika Therapeutics Inc.
- Salix Pharmaceuticals
- Others
Reports Description
According to Custom Market Insights (CMI), The Global Hyaluronic Acid Market was estimated at USD 1.1 billion in 2021 and is expected to reach USD 1.26 billion in 2022 and is anticipated to reach around USD 2.60 billion by 2030, growing at a CAGR of roughly 8% between 2022 and 2030. Our research report offers a 360-degree view of the Hyaluronic Acid market’s drivers and restraints, coupled with their impact on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the Hyaluronic Acid market.
- The fluids surrounding our eyes and joints, which serve as a lubricant and cushion for the tissues, have the highest quantities of hyaluronic acid. This glycosaminoglycan is naturally present in our bodies. It aids in keeping the skin’s moisture levels stable. Due to its ability to hold moisture, hyaluronic acid is frequently utilized in skincare products to promote softer, smoother, and more moisturized skin. For those with low quantities of hyaluronic acid, nutritional supplements containing hyaluronic acid are also sold on the market. Such glycosaminoglycan is a crucial lubricant in body joints and is also sought after in the medical sector to treat osteoarthritic joints’ inflammatory problems.
- Hyaluronic acid is obtained from rooster combs or produced in a laboratory by bacteria. Hyaluronic acid injections into the knee have been approved by the FDA for individuals with osteoarthritis of the knee. Patients with cataracts might also receive it as an injection into the eye. In 2021, the cosmetics application market had the largest market share. Dermal fillers are becoming popular, which is the key factor driving demand.
- According to L’Oréal’s Cosmetics Market Report 2020, COVID-19 had a substantial impact on the cosmetics market, causing a fall of about 8% in the first two quarters. However, the same survey claims that the existence of e-commerce platforms helped mitigate the effect to some extent, with online cosmetic sales expected to increase by 40% globally by the year 2020.
- However, a study of 1000 US women conducted by the American Society of Plastic Surgeons in April 2021 found that 70% of them planned to get a cosmetic surgery operation or a minimally invasive procedure after COVID-19. This demand will aid in the market’s recovery when COVID-19’s impacts start to fade.
Report Scope
The study’s focus is on Hyaluronic Acid market analysis on a global scale, and market sizing includes the income generated by these solutions provided by different market players. In order to support the market projections and growth rates over the anticipated period of 2025-2034, the study additionally monitors important market factors, underlying growth influencers, and significant vendors active in the sector. The study also examines how COVID-19 has affected the ecology generally. The scope of the study includes market sizing and forecast for segmentation by grade, application, end-user, and geography.
| Feature of the Report | Details |
| Market Size in 2021 | USD 1.1 Billion |
| Projected Market Size in 2030 | USD 2.60 Billion |
| Market Size in 2022 | USD 1.26 Billion |
| CAGR Growth Rate | 8% CAGR (2025-2034) |
| Base Year | 2023 |
| Forecast Period | 2025-2034 |
| Prominent Players | Allergan, Genzyme Corporation, Sanofi, Anika Therapeutics Inc., Salix Pharmaceuticals, F. Hoffmann-La Roche Ag, Seikagaku Corporation, Galderma Laboratories L.P., Smith & Nephew Plc, Zimmer Biomet, Ferring B.V., HTL Biotechnology, Lifecore Biomedical Llc, Shiseido Company Limited, LG Life Sciences Ltd (LG Chem.), Bloomage Biotechnology Corporation Limited, Maruha Nichiro Inc., and Others |
| Key Segment | By Grade, Application, End-users, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors, and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfill your requirements for research. |
Key Market Dynamics
- The aging population and the development of technologically sophisticated products are expected to drive market growth. In the upcoming years, the industry’s growth is anticipated to be driven by the growing preference for minimally invasive procedures and the need for quicker outcomes. The advent of cost-effective treatments and products, the aging population, growing aesthetic consciousness, and technology advancements are a few of the causes propelling the industry’s expansion.
- The number of aesthetic operations being performed is rising as a result of an increase in plastic surgeons and cosmetic surgery offices. The industry is being driven by the increasing use of nonsurgical cosmetic procedures like Botox and injectable hyaluronic acid. During the projection period, new product developments and an increase in the use of business strategies by important market participants, such as mergers and acquisitions, are expected to fuel growth. Hyaluronic acid has a number of health advantages that will increase demand, including moisture retention, quicker wound healing, relief from joint pain, prevention of dry eyes and discomfort, and preservation of bone strength.
- Two significant aspects that are projected to contribute to the expansion of the global hyaluronic acid market during 2025-2034 are the rise in chronic diseases and the rising cost of healthcare services. Additionally, the market for hyaluronic acid is growing as a result of minimally invasive procedures and rising awareness of beauty and wellness.
Osteoarthritis Application Led the Hyaluronic Acid Market
- In 2021, the OA led the sector globally and generated more than 40% of total sales. Due to a growth in the number of elderly people and a growing preference for minimally invasive procedures, the business is predicted to expand. Nearly 90% of viscosupplement prescriptions are meant to treat knee osteoarthritis. Both corticosteroids and hyaluronic acid injections can be used to treat osteoarthritis. According to the Osteoarthritis Research Society International (OARSI), the U.S., however, viscosupplementation is marginally more successful than corticosteroids.
- Viscosupplements are becoming more well-liked as a treatment, notwithstanding the large percentage of painkillers in pain management. The U.S. FDA approved the use of hyaluronan as a therapy for osteoarthritis in 1997, and it has since garnered a significant market share. The osteoarthritis market is further divided into three categories: single injections, three injections, and five injections. Despite having greater treatment costs than its competitors, the market has generally accepted the single hyaluronic acid injection. Single injections are more convenient and require fewer trips to the hospital while also causing less discomfort and negative side effects.
- Over the forecast period, the market growth is also anticipated to be aided by the rising occurrences of obesity and the growing senior population. Dermal fillers are the most popular and nonsurgical injectable therapy, specifically used to address soft tissue abnormalities on the face, according to the American Society of Plastic Surgeons (ASAPS). Dermal fillers made of hyaluronic acid are frequently used for aesthetic procedures such as reducing nasolabial folds, dark circles, eye wrinkles, and scarring. Hyaluronic acid injections are simple to administer, efficient, and substantially less expensive; these benefits are anticipated to fuel growth throughout the course of the forecast period.
Competitive Landscape
Tier-1 and tier-2 firms are prevalent in the global hyaluronic acid market. All of the companies in the industry are vying for the largest possible portion of the market, which is very competitive. Limited government approval and licenses and high investment in hyaluronic acid research and development boost rivalry among the competitors.
Our market analysis includes a section specifically devoted to key players operating in the Hyaluronic Acid Market. Our analysts give an overview of each player’s financial statements, along with product benchmarking and SWOT analysis. The competitive landscape section includes key development strategies, market share analysis, and market positioning analysis of the mentioned competitors globally.
- 2021: Three different types of hyaluronic acid have been introduced by Royal DSM, a multinational scientific corporation involved in nutrition, health, and sustainable living. These are HYA-ACTTM M Medium Molecular Weight products, which improve skin moisture and fortify the barrier of defense. While HYA-ACTTM XS Very Small Molecular Weight (MW 37-56 kDa) delivers a continual burst of strong hydration and smoothens out fine lines, HYA-ACTTM S Small Molecular Weight (MW 200-400 kDa) locks in moisture for an even greater hydration boost.
- 2020: Juvederm Voluma XC, a new hyaluronic acid product approved by AbbVie, is intended to improve the chin profile in adults.
The global Hyaluronic Acid market is segmented as follows:
By Grade
- Food
- Cosmetic
- Pharmaceutical
By Application
- Pharmaceutical API
- Aesthetics
- Osteoarthritis
- Cosmetics
- Ophthalmology
- Dietary Supplements
By End-users
- Pharmaceuticals Industry
- Cosmetic Surgery Centers
- Dermatology Clinics
- Food Industry
- Others
By Region
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research Methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Hyaluronic Acid Market, (2025 – 2034) (USD Billion)
- 2.2 Global Hyaluronic Acid Market : snapshot
- Chapter 3. Global Hyaluronic Acid Market – Industry Analysis
- 3.1 Hyaluronic Acid Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The hyaluronic acid market growth include increasing aesthetic consciousness
- 3.2.2 The aging population
- 3.2.3 The introduction of cost-effective treatments and products
- 3.2.4 Technological advancements.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Grade
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By End-users
- Chapter 4. Global Hyaluronic Acid Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Hyaluronic Acid Market: company market share, 2025
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Hyaluronic Acid Market – Grade Analysis
- 5.1 Global Hyaluronic Acid Market overview: By Grade
- 5.1.1 Global Hyaluronic Acid Market share, By Grade, 2025 and 2034
- 5.2 Food
- 5.2.1 Global Hyaluronic Acid Market by Food, 2022 – 2030 (USD Billion)
- 5.3 Cosmetic
- 5.3.1 Global Hyaluronic Acid Market by Cosmetic, 2022 – 2030 (USD Billion)
- 5.4 Pharmaceutical
- 5.4.1 Global Hyaluronic Acid Market by Pharmaceutical, 2022 – 2030 (USD Billion)
- 5.1 Global Hyaluronic Acid Market overview: By Grade
- Chapter 6. Global Hyaluronic Acid Market – Application Analysis
- 6.1 Global Hyaluronic Acid Market overview: By Application
- 6.1.1 Global Hyaluronic Acid Market share, By Application, 2025 and 2034
- 6.2 Pharmaceutical API
- 6.2.1 Global Hyaluronic Acid Market by Pharmaceutical API, 2022 – 2030 (USD Billion)
- 6.3 Aesthetics
- 6.3.1 Global Hyaluronic Acid Market by Aesthetics, 2022 – 2030 (USD Billion)
- 6.4 Osteoarthritis
- 6.4.1 Global Hyaluronic Acid Market by Osteoarthritis, 2022 – 2030 (USD Billion)
- 6.5 Cosmetics
- 6.5.1 Global Hyaluronic Acid Market by Cosmetics, 2022 – 2030 (USD Billion)
- 6.6 Ophthalmology
- 6.6.1 Global Hyaluronic Acid Market by Ophthalmology, 2022 – 2030 (USD Billion)
- 6.7 Dietary Supplements
- 6.7.1 Global Hyaluronic Acid Market by Dietary Supplements, 2022 – 2030 (USD Billion)
- 6.1 Global Hyaluronic Acid Market overview: By Application
- Chapter 7. Global Hyaluronic Acid Market – End-users Analysis
- 7.1 Global Hyaluronic Acid Market overview: By End-users
- 7.1.1 Global Hyaluronic Acid Market share, By End-users, 2025 and 2034
- 7.2 Pharmaceuticals Industry
- 7.2.1 Global Hyaluronic Acid Market by Pharmaceuticals Industry, 2022 – 2030 (USD Billion)
- 7.3 Cosmetic Surgery Centers
- 7.3.1 Global Hyaluronic Acid Market by Cosmetic Surgery Centers, 2022 – 2030 (USD Billion)
- 7.4 Dermatology Clinics
- 7.4.1 Global Hyaluronic Acid Market by Dermatology Clinics, 2022 – 2030 (USD Billion)
- 7.5 Food Industry
- 7.5.1 Global Hyaluronic Acid Market by Food Industry, 2022 – 2030 (USD Billion)
- 7.6 Others
- 7.6.1 Global Hyaluronic Acid Market by Others, 2022 – 2030 (USD Billion)
- 7.1 Global Hyaluronic Acid Market overview: By End-users
- Chapter 8. Hyaluronic Acid Market – Regional Analysis
- 8.1 Global Hyaluronic Acid Market Regional Overview
- 8.2 Global Hyaluronic Acid Market Share, by Region, 2025 & 2030 (USD Billion)
- 8.3. North America
- 8.3.1 North America Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.3.1.1 North America Hyaluronic Acid Market, by Country, 2022 – 2030 (USD Billion)
- 8.3.1 North America Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.4 North America Hyaluronic Acid Market, by Grade, 2022 – 2030
- 8.4.1 North America Hyaluronic Acid Market, by Grade, 2022 – 2030 (USD Billion)
- 8.5 North America Hyaluronic Acid Market, by Application, 2022 – 2030
- 8.5.1 North America Hyaluronic Acid Market, by Application, 2022 – 2030 (USD Billion)
- 8.6 North America Hyaluronic Acid Market, by End-users, 2022 – 2030
- 8.6.1 North America Hyaluronic Acid Market, by End-users, 2022 – 2030 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.7.1.1 Europe Hyaluronic Acid Market, by Country, 2022 – 2030 (USD Billion)
- 8.7.1 Europe Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.8 Europe Hyaluronic Acid Market, by Grade, 2022 – 2030
- 8.8.1 Europe Hyaluronic Acid Market, by Grade, 2022 – 2030 (USD Billion)
- 8.9 Europe Hyaluronic Acid Market, by Application, 2022 – 2030
- 8.9.1 Europe Hyaluronic Acid Market, by Application, 2022 – 2030 (USD Billion)
- 8.10 Europe Hyaluronic Acid Market, by End-users, 2022 – 2030
- 8.10.1 Europe Hyaluronic Acid Market, by End-users, 2022 – 2030 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.11.1.1 Asia Pacific Hyaluronic Acid Market, by Country, 2022 – 2030 (USD Billion)
- 8.11.1 Asia Pacific Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.12 Asia Pacific Hyaluronic Acid Market, by Grade, 2022 – 2030
- 8.12.1 Asia Pacific Hyaluronic Acid Market, by Grade, 2022 – 2030 (USD Billion)
- 8.13 Asia Pacific Hyaluronic Acid Market, by Application, 2022 – 2030
- 8.13.1 Asia Pacific Hyaluronic Acid Market, by Application, 2022 – 2030 (USD Billion)
- 8.14 Asia Pacific Hyaluronic Acid Market, by End-users, 2022 – 2030
- 8.14.1 Asia Pacific Hyaluronic Acid Market, by End-users, 2022 – 2030 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.15.1.1 Latin America Hyaluronic Acid Market, by Country, 2022 – 2030 (USD Billion)
- 8.15.1 Latin America Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.16 Latin America Hyaluronic Acid Market, by Grade, 2022 – 2030
- 8.16.1 Latin America Hyaluronic Acid Market, by Grade, 2022 – 2030 (USD Billion)
- 8.17 Latin America Hyaluronic Acid Market, by Application, 2022 – 2030
- 8.17.1 Latin America Hyaluronic Acid Market, by Application, 2022 – 2030 (USD Billion)
- 8.18 Latin America Hyaluronic Acid Market, by End-users, 2022 – 2030
- 8.18.1 Latin America Hyaluronic Acid Market, by End-users, 2022 – 2030 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Hyaluronic Acid Market, by Country, 2022 – 2030 (USD Billion)
- 8.19.1 The Middle-East and Africa Hyaluronic Acid Market, 2022 – 2030 (USD Billion)
- 8.20 The Middle-East and Africa Hyaluronic Acid Market, by Grade, 2022 – 2030
- 8.20.1 The Middle-East and Africa Hyaluronic Acid Market, by Grade, 2022 – 2030 (USD Billion)
- 8.21 The Middle-East and Africa Hyaluronic Acid Market, by Application, 2022 – 2030
- 8.21.1 The Middle-East and Africa Hyaluronic Acid Market, by Application, 2022 – 2030 (USD Billion)
- 8.22 The Middle-East and Africa Hyaluronic Acid Market, by End-users, 2022 – 2030
- 8.22.1 The Middle-East and Africa Hyaluronic Acid Market, by End-users, 2022 – 2030 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Allergan
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Genzyme Corporation
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Sanofi
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Anika Therapeutics Inc.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Salix Pharmaceuticals
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 F. Hoffmann-La Roche Ag
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Seikagaku Corporation
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Galderma Laboratories L.P.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Smith & Nephew Plc
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Zimmer Biomet
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Ferring B.V.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 HTL Biotechnology
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Lifecore Biomedical Llc
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Shiseido Company Limited
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 LG Life Sciences Ltd (LG Chem.)
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Bloomage Biotechnology Corporation Limited
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Maruha Nichiro Inc.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.1 Allergan
List Of Figures
Figures No 1 to 30
List Of Tables
Tables No 1 to 77
-
List of the prominent players in the global Hyaluronic Acid market:
- Allergan
- Genzyme Corporation
- Sanofi
- Anika Therapeutics Inc.
- Salix Pharmaceuticals
- Hoffmann-La Roche Ag
- Seikagaku Corporation
- Galderma Laboratories L.P.
- Smith & Nephew Plc
- Zimmer Biomet
- Ferring B.V.
- HTL Biotechnology
- Lifecore Biomedical, Llc
- Shiseido Company Limited
- LG Life Sciences Ltd (LG Chem.)
- Bloomage Biotechnology Corporation Limited
- Maruha Nichiro Inc.
- Others
FAQs
“North America” region will lead the global Hyaluronic Acid market during the forecast period 2022 to 2030.
The key factors driving the market are the hyaluronic acid market growth include increasing aesthetic consciousness, the aging population, the introduction of cost-effective treatments and products, and technological advancements.
The key players operating in the Hyaluronic Acid market are Allergan, Genzyme Corporation, Sanofi, Anika Therapeutics Inc., Salix Pharmaceuticals, F. Hoffmann-La Roche Ag, Seikagaku Corporation, Galderma Laboratories L.P., Smith & Nephew Plc, Zimmer Biomet, Ferring B.V., HTL Biotechnology, Lifecore Biomedical Llc, Shiseido Company Limited, LG Life Sciences Ltd (LG Chem.), Bloomage Biotechnology Corporation Limited, Maruha Nichiro Inc.
The global Hyaluronic Acid market is expanding growth with a CAGR of approximately 8% during the forecast period (2022 to 2030).
The global Hyaluronic Acid market size was valued at USD (1.1 billion) in 2021 and it is projected to reach around USD (2.6 billion) by 2030.